With growing applications of DNA in medical research, industry stakeholders are actively looking for technologies that not only facilitate parallelized synthesis of DNA but also provide unmatched precision, scalability, and speed
Roots Analysis has announced the addition of “DNA Synthesis Technologies and Services Market, 2022-2035” report to its list of offerings.
With an increased focus on automating DNA synthesis technologies, several developers have incorporated robust automatic techniques that enable the engineering of biological systems and study genome in a high throughput manner. This further leads to an increase in the yield of high-fidelity DNA fragments for use across several drug discovery and drug development processes
To order this 290+ page report, which features 130+ figures and 100+ tables, please visit
https://www.rootsanalysis.com/reports/dna-synthesis-market.html
Key Market Insights
Currently, more than 65 technology / service providers claim to offer DNA synthesis technologies and services
Majority of the stakeholders (53%) in this market claim to offer DNA synthesis services. A large proportion (56%) of these companies are small players, followed by mid-sized (28%) and large firms (18%).
Partnership activity within this domain has increased between 2017-2022
During the given time period, acquisition (40%) was the most common type of partnership model adopted by the companies involved in the DNA synthesis technologies and services domain. This was followed by technology licensing deals (20%), manufacturing (9%), product development (9%) and platform development agreements (6%).
Over USD 800 million has been invested by both private and public investors, since 2017
Of the total, close to USD 580 billion was raised through venture capital financing, representing around 40% of the overall investment. On the other hand, instances (29%) of grants were also reported, wherein players collectively raised more than USD 40 million.
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact:
Ben Johnson
+1 (415) 800 3415
